Journals in Molecular genetics

Cancer Letters

ISSN: 0304-3835
5 Year impact factor: 8.3
Impact factor: 9.1

An international journal providing a forum for original and pertinent contributions in cancer researchCancer Letters is an international journal that considers full-length articles and Mini Reviews in the broad area of basic and translational oncology. Additionally, Special Issues highlight topical areas in cancer research. Basic areas of interest to a broad readership of Cancer Letters include the molecular genetics and cell biology of cancer, radiation biology, molecular pathology, hormones and cancer, viral oncology, metastasis, and chemoprevention. The journal places emphasis on experimental therapeutics, particularly targeted therapies for personalized cancer medicine, including metronomic chemotherapy.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: https://service.elsevier.com.

Subscriptions

Current Opinion in Genetics & Development

ISSN: 0959-437X
5 Year impact factor: 4.1
Impact factor: 3.7

Current Opinion in Genetics and Development aims to stimulate scientifically grounded, interdisciplinary, multi-scale debate and exchange of ideas. It contains polished, concise and timely reviews and opinions, with particular emphasis on those articles published in the past two years. In addition to describing recent trends, the authors are encouraged to give their subjective opinion of the topics discussed.In Current Opinion in Genetics and Development we help the reader by providing in a systematic manner:1. The views of experts on current advances in their field in a clear and readable form. 2. Evaluations of the most interesting papers, annotated by experts, from the great wealth of original publications.Current Opinion in Genetics and Development is part of the Current Opinion and Research (CO+RE) suite of journals . CO+RE journals leverage the Current Opinion legacy of editorial excellence, high-impact, and global reach to ensure they are a widely-read resource that is integral to scientists' workflows.Current Opinion in Genetics and Development will serve as an invaluable source of information for researchers, lecturers, teachers, professionals, policy makers and students.Division of the subject into sectionsThe subject of Genetics and Development is divided into six themed sections, each of which is reviewed once a year:• Cancer Genomics • Genome Architecture and Expression • Molecular and genetic basis of disease • Developmental mechanisms, patterning and evolution • Cell reprogramming, regeneration and repair • Genetics of Human Origin / Evolutionary genetics (alternate years)Selection of topics to be reviewedSection Editors, who are major authorities in the field, are appointed by the Editors of the journal. They divide their section into a number of topics, ensuring that the field is comprehensively covered and that all issues of current importance are emphasised. Section Editors commission reviews from authorities on each topic that they have selected. The Editorial Board provides support to the Editors and the Section Editors with their comments and suggestions on names and topics.Review articles in Current Opinion in Genetics and Development are by invitation only.Review ArticlesThe Current Opinion journals were developed out of the recognition that it is increasingly difficult for specialists to keep up to date with the expanding volume of information published in their subject. In the Current Opinion journals, we help the reader by providing in a systematic manner: (1) The views of experts on current advances in the field in a clear and readable form. (2) Evaluations of the most interesting papers, annotated by experts, from the great wealth of original publications.The aim of the manuscript is to review recent articles, with particular emphasis on those articles published in the past two years. In addition to describing recent trends, you are encouraged to give your subjective opinion of the topics discussed, although you should not concentrate unduly on your own research. Your review should be approximately 2000 words (not including references or reference notes), with approximately 50 references and, as such, the review is intended to be a concise view of the field as it is at the moment, rather than a comprehensive overview. Our audience ranges from student to professor, so articles must be accessible to a wide readership. Please avoid jargon, but do not oversimplify: be accurate and precise throughout. Occasionally, unpublished data can be referred to, but only when essential and should never be used to substantiate any significant point.Please see further information under Writing and Formatting – Additional information. Editorial OverviewSection Editors write a short overview at the beginning of the section to introduce the reviews and to draw the reader's attention to any particularly interesting developments.This successful format has made Current Opinion in Genetics and Development one of the most highly regarded and highly cited review journals in the field.

Subscriptions

DNA Repair

ISSN: 1568-7864
5 Year impact factor: 3.7
Impact factor: 3

DNA Repair (DNAREP) is a journal focusing on DNA repair and cellular responses to DNA damage. DNA Repair publishes articles on genetic, cellular, biochemical, structural and molecular aspects of DNA repair. The journal welcomes articles describing databases, methods and new technologies supporting research on DNA repair and responses to DNA damage. Letters to the Editor, hot topics and classics in DNA repair, historical reflections, book reviews and meeting reports will also be considered for publication.The journal publishes topics directly pertaining to DNA damage and repair, which include:ApoptosisBiological responses to genomic insultCell cycle regulationCell fate decisionsEpigenetics and chromatinGenomics/bioinformaticsHuman diseases: aging, cancer, and neurological dysfunctionImmune responsesMutagenesis & signature mutationsStructural biology and computational modeling

Subscriptions

Gene

ISSN: 0378-1119
5 Year impact factor: 2.7
Impact factor: 2.6

Gene publishes papers that focus on the regulation, expression, function, and evolution of genes in all biological contexts, including all prokaryotic and eukaryotic organisms, as well as viruses.Gene supports open access and strives to be an international and diverse journal.The following topics, each headed up by a Section Editor who is an expert in the field, are considered for publication:Human Genetics: Encompasses the fields of molecular genetics, cytogenetics, biochemical genetics, population genetics, evolutionary genetics, developmental genetics, and clinical genetics. We welcome articles aimed at understanding the molecular basis of human diseases, the genetic diversity and evolution of human populations, and the developmental processes that shape human phenotypes (applications in medicine, biotechnology, forensics, anthropology, and bioethics).Cancer Genetics: We welcome high-quality scientific papers on the cellular, genetic and molecular aspects of cancer, including cancer predisposition and clinical diagnostic applications. Specific areas of interest include descriptions of new chromosomal, molecular, or epigenetic alterations in benign and malignant diseases; novel laboratory approaches for identification and characterization of chromosomal rearrangements or genomic alterations in cancer cells; correlation of genetic changes with pathology and clinical presentation; and the molecular genetics of cancer predisposition.Neurogenetics: The focus is to understand how genetic variations influence the structure and activity of neurons, glia, and neural circuits, as well as how they affect the risk and progression of neurological and psychiatric disorders. We also welcome articles, reviews, and short communications on gene expression and regulation that are modulated by environmental factors and neural activity and how gene therapy can be used to treat or prevent neurological diseases.Animal Genetics: We welcome original manuscripts, reviews, and short reports on frontline research on the molecular genetics, functional genomics, and microbiomics of livestock, marine animals, wildlife, and laboratory animals. Publications may include studies of variation in proteins, metabolomes, genes, transcriptomes, and genomes in relation to phenotypes, mapping of traits gene editing, genetic diversity and epidemiology, epigenetics, epigenomics, multi-omics, and microbiomes.Some of the topics that animal genetics covers are - Inheritance: How genes are passed from parents to offspring and how they determine the physical and behavioral features of animals. - Variation: How genes interact with each other and with the environment to create differences among individuals and populations of animals. - Selection: How natural or artificial forces affect the frequency and distribution of genes and traits in animal populations. - Genetic engineering: How biotechnology can modify the genetic makeup of animals for various purposes, such as improving disease resistance, enhancing performance, or creating transgenic animals. - Genetic testing: How molecular techniques can identify the genetic status of animals for diagnosis, screening, or identification purposes.Genome Editing: We welcome submissions within the field of gene editing, covering various document types, such as reviews, research papers, or short communications on the latest findings and translational research in this evolving area.The broad focus of this section encompassesInvestigations into the regulatory mechanisms of gene editing, exploration of genetic pathways, and specific genes impacting gene editing in both prokaryotic and eukaryotic systemsGene editing of somatic and stem cells for all organismsTherapeutic development of novel gene editing tools for the treatment of cancer and inherited diseasesDevelopment of new research tools, such as single-agent applications with oligonucleotides and programmable nucleases, including but not limited to CRISPR/Cas systemsInnovation concerning biomolecular tools that advance genetic engineering objectivesAdditionally, we encourage the submission of reviews or research articles describing the appropriate use of gene editing in eukaryotic and prokaryotic organisms, with a special emphasis on ethical regulation and guidance provided by the appropriate regulatory agencies.Molecular Ecology: We welcome articles, reviews, and short communications that investigate how environmental factors affect the distribution and abundance of species; how species respond to climate change, habitat fragmentation, and invasive species; how gene expression and epigenetics influence phenotypic variation and plasticity; and how hybridization and introgression shape the genetic structure and speciation of populations. We also aim at publishing articles, reviews, and short communications that address molecular ecology, which provides insights into the ecological and evolutionary processes that shape biodiversity and the functioning of ecosystems.Plant Genetics: We welcome manuscripts, reviews, short communication that focus on the molecular mechanisms and evolutionary processes that shape the diversity and function of plant genomes. Topics may include the use of various tools and techniques, such as molecular markers, gene editing, transcriptomics, proteomics, and bioinformatics to investigate the structure, expression, regulation, and interaction of plant genes. Also, applications in agriculture, biotechnology, medicine, and conservation are of interest to Gene.Parasitology and Virology: The focus of this branch is to understand the biology and diversity of parasites and viruses, to identify their modes of transmission and pathogenesis, to develop diagnostic tools and preventive measures, and to find effective treatments and vaccines.We aim at publishing research papers, reviews, and communications related to parasite biology, with particular attention to the effects and physiological alterations to their hosts and vectors and to the strategies implemented by parasites to transmit between hosts and counteract their immune defenses.Microbiology: We welcome articles, reviews, and short communications that investigate microbiology in relation to applications in medicine, biotechnology, agriculture, food safety, and environmental engineering.Out of scope areComputational/bioinformatic studies without solid experimental validation of the computed findingsCase report studies reporting solely descriptive observations with no genetic implicationsMendelian randomization studies and meta-analysesAny descriptive study that has no genetic implicationsGene is part of the Gene Family, and you are welcome to submit toGene Reports (Impact Factor 1.3)Human Gene (Impact Factor 0.7)Plant Gene (under Impact Factor review)

Subscriptions

Gene Expression Patterns

ISSN: 1567-133X
5 Year impact factor: 1
Impact factor: 1

Gene Expression Patterns is devoted to the rapid publication of high quality studies of gene expression in development. Studies using cell culture are also suitable if clearly relevant to development, e.g., analysis of key regulatory genes or of gene sets in the maintenance or differentiation of stem cells. Key areas of interest include:In-situ studies such as expression patterns of important or interesting genes at all levels, including transcription and protein expressionTemporal studies of large gene sets during developmentTransgenic studies to study cell lineage in tissue formation"Omic" studies: In addition of the aims described above, Gene Expression Patterns will publish "Omics" studies (genomics, transcriptomic, proteomics, including single cell RNAseq, etc) relevant for embryo development.

Subscriptions

Infection, Genetics and Evolution

ISSN: 1567-1348
5 Year impact factor: 2.6
Impact factor: 2.6

Infection, Genetics and Evolution welcomes articles dealing with genetics, population genetics, genomics, gene expression, population dynamics, mathematical modeling, bioinformatics, and any related area that contributes to improve our understanding of the genetics and evolutionary biology of hosts, pathogens and vectors, as well as coevolution processes among them in relation to infections and infectious diseases manifestations. All infectious models enter the scope of the journal, including pathogens of humans, animals, and plants, either parasites, fungi, bacteria, viruses or prions.Please note the following topics are not within scope and will be immediately rejected:In silico vaccine developmentIn vitro testing of new drugs or compoundsClinical microbiology with no relationship to geneticsComputational re-analysis of gene expression dataInfection, Genetics and Evolution and its companion congress MEEGID (for Molecular Epidemiology and Evolutionary Genetics of Infectious Diseases) are the main forum acting for the cross-fertilization between evolutionary science and biomedical research on infectious diseases.

Subscriptions

Journal of Biotechnology

ISSN: 0168-1656
5 Year impact factor: 3.6
Impact factor: 4.1

The Journal of Biotechnology (J. Biotech.) offers publication for both full-length articles and short communications on a wide range of biotechnology-related topics. Also, review articles can be submitted if they are pre-approved by one of the editors. The journal will only accept submissions with novel scientific research results that are directly relevant to biotechnological systems and/or applications (for details, please see the list below). J. Biotech. has strict rules about plagiarism. Any submission that includes parts of already published material will be rejected. This includes any attempt to re-publish already published Materials and Methods paragraphs. The journal features a "one-pass review process," i.e., eligible submissions will be reviewed, and those that need improvements (either minor or major) can be resubmitted only once before the decision about whether to accept or reject is decided by the Chief Editor. All figures need to be submitted as high-resolution files during the initial submission. All articles must be written in English, and the quality of the English language will be one of the criteria during the review process.Main Scope of the Journal:Bioprocess engineeringSystem biology, synthetic microbiologyMetabolic engineering, microbial physiologyBiorefinery, biomass engineeringBiochemical enzyme/protein engineeringMetabolic engineeringMicrobial expression systemsBiocatalyst engineeringInsect cell-based modelsMultienzyme cascade reactionsPlant-based biotechnologyOutside of the Scope:Manuscripts lacking noveltyReview articles submitted without previous invitation/confirmation by an editorEnvironmental-related subjects, e.g., waste-water treatment, bioremediation, biodegradationReports on the cloning and/or expression of naturally occurring enzymes without direct biotechnological applicationResearch on natural products without biotechnological modificationToxicological researchPharmacological researchFood science-related research without biotechnological applicationEngineering articles that do not deal with the direct improvement of biotechnological processesGenome research, especially genome sequencing reportsBenefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Subscriptions

Molecular Immunology

ISSN: 0161-5890
5 Year impact factor: 3.6
Impact factor: 3.2

Molecular Immunology publishes original articles, reviews and commentaries on all areas of immunology, with a particular focus on description of cellular, biochemical or genetic mechanisms underlying immunological phenomena. Studies on all model organisms, from invertebrates to humans, are suitable. Examples include, but are not restricted to:Infection, autoimmunity, transplantation, immunodeficiencies, inflammation and tumor immunologyMechanisms of induction, regulation and termination of innate and adaptive immunityIntercellular communication, cooperation and regulationIntracellular mechanisms of immunity (endocytosis, protein trafficking, pathogen recognition, antigen presentation, etc)Mechanisms of action of the cells and molecules of the immune systemStructural analysisDevelopment of the immune systemComparative immunology and evolution of the immune system"Omics" studies and bioinformaticsVaccines, biotechnology and therapeutic manipulation of the immune system (therapeutic antibodies, cytokines, cellular therapies, etc)Technical developmentsArticles based primarily on studies in silico must adhere to the following principles; (i) The article must report novel analytical tools, approaches and/or databases rather than using publicly available ones; or (ii) The article must include substantial experimental validation of the conclusions obtained in silico.Manuscripts related to regulatory RNA (e.g. microRNAs, lncRNAs or circRNAs) are welcome but please note: (i) they must show clear physiological relevance supported by in vivo results or clinical observations; (ii) Correlations between regulatory RNA expression with human diseases should be experimentally validated; (iii) Functions associated with the regulatory RNAs must within the scope of the journal i.e. inflammation and/or immune responses.To be acceptable for publication, studies that describe correlations between disease and genetic polymorphisms would normally be required to include novel mechanistic findings underlying the associations.Clinical studies correlating disease and measurements of a molecule or cell type would likewise not be suitable for publication without novel mechanistic insights.Studies describing pharmacological agents are welcome if they provide significant novelty on the mechanisms of action.

Subscriptions

Molecular and Biochemical Parasitology

ISSN: 0166-6851
5 Year impact factor: 1.6
Impact factor: 1.4

Molecular and Biochemical Parasitology provides a medium for rapid publication of investigations of the molecular biology and biochemistry of parasitic protozoa and helminths and their molecular interactions with their definitive and intermediate hosts and their vectors.The main subject areas covered are:the structure, biosynthesis, degradation, properties and function of parasite biomolecules - DNA, RNA, proteins, lipids, carbohydrates and small molecular-weight substanceshost-parasite relationships particularly as related to specific parasite molecules and to the response of host cells to infectionvector-parasite relationships at the molecular levelintermediary metabolism and bioenergeticsdrug target characterization and the mode of action of antiparasitic drugsanalysis of gene function, expression, and of genome structure and stabilityanalysis of variation in parasite populations relevant to genetic exchange, pathogenesis, drug and vaccine target characterization, and drug resistance; please note that genetic variation data must be supported by phenotypic/experimental data showing the effect of the variation, and that papers reporting solely on allele frequencies in specific regions will not be accepted.parasite protein trafficking, organelle biogenesis, and cellular structure especially with reference to the roles of specific moleculesmolecular and biochemical aspects of membrane structure and functionparasite programmed cell death, development, and cell division at the molecular levelmethods reports - descriptions of novel or newly-optimized methods with broad applicability to molecular and biochemical parasitologyPapers will only be accepted for publication if they fall within these areas, if they contain original and complete work of high scientific quality, and if they are well presented. Papers solely confirming the conserved functions of genes previously studied in other organisms will not be considered. We welcome short communications documenting a succinct but clear and important advance.1. Original research articles should report highly significant innovative results not previously published elsewhere. Original articles are limited to 7,000 words per article (all text excluding tables and figure legends).2. Short Communications need not be formally structured as full papers but should describe significant new findings and observations. The manuscript should ideally contain no more than 4Figures/Tables and 3000 words. The abstract should be limited to 200 words.3. Methods Reports should contain descriptions of novel or newly-optimised methods with broad applicability to molecular parasitologists. The manuscript should ideally contain no more than 4 Figures/Tables and 3000 words. Results and Discussion are usually combined. The abstract should be limited to 200 words. Methods Reports must include a detailed step-by-step protocol and/or analysis code in the supplementary material.4. Review articles should cover subjects falling within the scope of the journal which are of active current interest. They may be submitted or invited by the Editors. Review articles should include insightful recommendations for future directions needed for achieving public health impacts. Review articles are limited to 15,000 words per article (all text excluding tables and figure legends). If you have a suggestion for a Review article topic please email Special Content Editor, Geoff Gobert: [email protected]. Perspective articles should include scientifically backed points of view regarding currently relevant, controversial or future-oriented topics pertinent to the scope of MBP. Note that only outlining recent advances in a given field is not acceptable for a Perspective article. Besides stimulating scientific discussion or future research, perspective articles should provide a novel conceptual framework for an old or timely issue. The authors should outline which research directions should be prioritized and highlight specific points explaining why they should be prioritized in future research. Perspective articles are limited to 6,000 words per article (all text excluding tables and figure legends).6. Letters to the Editor offering comment or useful critique on material published in the journal are welcome. Letters on "hot topics" are also welcome. Note that Letters to the Editors will also be externally reviewed but the decision to publish submitted letters rests with the Editors in Chief. A goal is to publish constructive letters that will permit an exchange of views which will be of benefit to both the journal and its readers. Letters to the Editor are limited to 2,000 words per article (all text excluding tables and figure legends).Most downloaded papersBenefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Subscriptions

Mutation Research: Reviews in Mutation Research

ISSN: 1383-5742
5 Year impact factor: 6.4
Impact factor: 6.4

The subject areas of Mutation Research - Reviews in Mutation Research (MRR) encompass the entire spectrum of the science of mutation research and its applications, with particular emphasis on the relationship between mutation and disease. Thus, this section will cover:Advances in human genome research (including evolving technologies for mutation detection and functional genomics) with applications in clinical genetics, gene therapy and health risk assessment for environmental agents of concernGenetic toxicology and environmental mutagenesis (including the factors that modulate the genetic activity of environmental agents) will continue to be prominent topics in this section.MRR supports and follows the general direction proposed by all major societies in the field part of the International Association of Environmental Mutagenesis and Genomics Societies (IAEMGS):Asociacion Latinoamericana de Mutagenesis, Carcinogenesis y Teratogenesis Ambiental (ALAMCTA)Brazilian Association of Mutagenesis and Environmental Genomics (MutaGen-Brasil)Chinese Environmental Mutagen Society (CEMS)European Environmental Mutagenesis and Genomics Society (EEMGS)Environmental Mutagenesis and Genomics Society (EMGS)Environmental Mutagen Society of India (EMS India)Iranian Environmental Mutagen Society (IrEMS)The Japanese Environmental Mutagen Society (JEMS)Korean Environmental Mutagen Society (KEMS)Molecular and Experimental Pathology Society of Australasia (MEPSA)Pan-African Environmental Mutagen Society (PAEMS)Philippines Environmental Mutagen Society (PEMS)Thai Environmental Mutagen Society (TEMS)Other Mutation Research sections: DNA Repair Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis (MR) Mutation Research - Genetic Toxicology and Environmental Mutagenesis (MRGTEM)

Subscriptions

Life Sciences

Physical Sciences & Engineering

Social Sciences & Humanities

Health

Journals in Molecular genetics

Cancer Letters

Current Opinion in Genetics & Development

DNA Repair

Gene

Gene Expression Patterns

Infection, Genetics and Evolution

Journal of Biotechnology

Molecular Immunology

Molecular and Biochemical Parasitology

Mutation Research: Reviews in Mutation Research